2-((S)-((2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxytetrahydrofuran-2-yloxy)((2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)-N-dodecyl-1,4-dimethyl-3-oxo-2,3,4,7-tetrahydro-1H-1,4-diazepine-5-carboxamide

ID: ALA4482948

PubChem CID: 71653799

Max Phase: Preclinical

Molecular Formula: C34H56N6O11

Molecular Weight: 724.85

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCNC(=O)C1=CCN(C)[C@@H]([C@H](O[C@@H]2O[C@H](CN)[C@@H](O)[C@H]2O)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)C(=O)N1C

Standard InChI:  InChI=1S/C34H56N6O11/c1-4-5-6-7-8-9-10-11-12-13-16-36-30(46)20-14-17-38(2)23(31(47)39(20)3)28(51-33-27(45)24(42)21(19-35)49-33)29-25(43)26(44)32(50-29)40-18-15-22(41)37-34(40)48/h14-15,18,21,23-29,32-33,42-45H,4-13,16-17,19,35H2,1-3H3,(H,36,46)(H,37,41,48)/t21-,23+,24-,25+,26-,27-,28+,29+,32-,33+/m1/s1

Standard InChI Key:  USBCRGSIUDLQJF-AFHNBZIUSA-N

Molfile:  

 
     RDKit          2D

 54 57  0  0  0  0  0  0  0  0999 V2000
   27.6410  -19.5130    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.8764  -18.7059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3910  -21.3697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4430  -20.6923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9174  -17.2391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7277  -20.5463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9939  -19.3314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8680  -22.0045    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.4695  -21.8719    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.6013  -22.1630    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.8957  -22.3873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4710  -20.2007    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.9112  -19.3437    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.4407  -19.3065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1886  -19.3630    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.0427  -21.9986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7883  -21.2071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2175  -22.7543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4950  -20.9769    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   29.0810  -18.1359    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.2327  -20.4294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.4030  -19.6176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7750  -19.0644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2795  -21.8755    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.8278  -20.1433    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.3255  -22.4028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2811  -21.5000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.9602  -21.2071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5331  -21.3496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6173  -21.9829    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.2100  -20.5688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7183  -20.4180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3819  -16.5617    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.1806  -19.7823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3871  -19.9234    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.0590  -18.8136    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.1841  -18.9495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1270  -21.0020    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   28.2707  -17.9829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0338  -20.3977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3166  -23.2273    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.9317  -20.1643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8958  -18.5329    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   25.1866  -21.9659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4670  -22.3693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7579  -21.9477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0382  -22.3511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3292  -21.9296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6095  -22.3330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9004  -21.9115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1808  -22.3149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4716  -21.8934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4821  -21.0684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2017  -20.6652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 23  7  2  0
 42 31  1  0
 39  2  1  0
  3 10  2  0
 39  5  1  1
 14  1  1  6
  7 25  1  0
 31  3  1  0
  4 27  2  0
 13 37  1  0
 37 20  1  0
  6 12  1  0
 12 31  1  0
  5 33  1  0
 26 41  2  0
 20 39  1  0
 42 13  1  6
 28 17  1  0
 40 25  1  1
 32 35  1  0
  8 18  1  0
 40 35  1  0
 22 23  1  0
  2 36  1  6
 17 24  1  6
 32 38  1  6
 28 32  1  0
 14 37  1  0
 16  8  1  0
 28  9  1  6
 37 43  1  6
 29 16  2  0
 30 11  1  0
 32 42  1  0
  4 21  1  0
 12 34  1  0
  3  8  1  0
  6 29  1  0
 22 15  2  0
 16 26  1  0
 25  4  1  0
  2 14  1  0
 21 22  1  0
 26 30  1  0
 17 40  1  0
 31 19  1  6
 11 44  1  0
 44 45  1  0
 45 46  1  0
 46 47  1  0
 47 48  1  0
 48 49  1  0
 49 50  1  0
 50 51  1  0
 51 52  1  0
 52 53  1  0
 53 54  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4482948

   (2S)-2-[(S)-[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxy-tetrahydrofuran-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl]-N-dodecyl-1,4-dimethyl-3-oxo-2,7-dihydro-1,4-diazepine-5-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 724.85

Molecular Weight (Monoisotopic): 724.4007

AlogP: -1.36

#Rotatable Bonds: 18

Polar Surface Area: 242.14

Molecular Species: BASE

HBA: 14

HBD: 7

#RO5 Violations: 3

HBA (Lipinski): 17

HBD (Lipinski): 8

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 9.70

CX Basic pKa: 8.75

CX LogP: -0.62

CX LogD: -1.79

Aromatic Rings: 1

Heavy Atoms: 51

QED Weighted: 0.09

Np Likeness Score: 0.74

References

1. Patel B, Ryan P, Makwana V, Zunk M, Rudrawar S, Grant G..  (2019)  Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.,  171  [PMID:30933853] [10.1016/j.ejmech.2019.01.071]

2. Arbour CA,Imperiali B.  (2020)  Uridine natural products: Challenging targets and inspiration for novel small molecule inhibitors.,  28  (18): [PMID:32828427] [10.1016/j.bmc.2020.115661]

Source

Source(1):

• Scientific Literature